Unaudited Financial Results for the Quarter ended 31st March,2008
(RS. IN LACS)
PARTICULARS Unaudited
Qtr.31.03.08		 Reviewed
Qtr.31.03.07		 Unaudited
Year End 31.03.08		 Audited
year end 31.03.07
INCOME FROM OPERATIONS 14141.28 10312.54 50338.45 37768.84
OTHER INCOME 10.20 21.78 396.57 203.70
TOTAL INCOME 14181.48 10334.32 50635.02 37972.54
EXPENDITURE        
INC. (-)/DEC. (+) IN STOCK AND W.I.P. -3057.71 -1928.74 -4600.34 -6350.22
CONSUMPTION OF RAW MATERIAL 7838.65 4950.02 21709.54 18159.36
PURCHASE OF TRADED GOODS 5265.36 4739.42 19171.22 15670.46
EMPLOYEES COST 396.93 419.37 1620.09 1451.28
DEPRECIATION 120.00 112.85 600.00 334.25
OTHER EXPENDITURE 1644.92 882.27 5426.64 4078.30
TOTAL EXPENDITURE 12208.15 9175.19 43927.15 33343.43
INTEREST 837.09 534.47 2931.53 1765.21
PROFIT BEFORE TAX 1136.24 624.37 3776.34 2863.90
PROVISION FOR TAX(INCL.FBT) 145.74 79.56 476.86 366.73
PROVISION FOR DEFFERED TAX 50.00 89.72 500.00 411.90
NET PROFIT 940.50 455.38 2799.48 2085.18
SHARE CAPITAL 743.57 743.57 743.57 743.57
RESERVE EXCLUDING REVALUATION RESERVE       14116.69
E.P.S.(Rs.) RATE/SHARE Rs.2/- 2.53 1.22 7.53 5.61
PUBLIC SHAREHOLDING
- NUMBER OF SHARES 2363517 23985890 23633517 23985890
- PERCENTAGE OF SHARES 63.57 64.51 63.57 64.51
 
Notes:-

1.During the quarter under review, the Income of the Company has grown by grown  by 37% and profit Before Tax  has shown an increase of 82% as compared to the same period in the previous year.

2.The Company is exclusive in the pharmaceutical business segment only

3. Information on investor's complaints for the quarter: opening-Nil, Received-4, Resolved-4, Pendin-Nil.

4.The above results were taken on record by the Audit Committee and Board of Directors at their respective  meetings held on 28th April, 2008
On behalf of the Board
 
Dated:28th April 2008  
(S.R. Mehta)
Place: Chandigarh  
Chairman